1-4 of 4
Sanil Bhatia, PhD
Close
Sort by
Journal Articles

Therapeutic Stratification of PTEN-MYC Axis Appears to be Promising for Molecular Targeted Therapies in Refractory and Relapsed T-Cell Acute Lymphoblastic Leukemia

Heinz Ahlert, MSc, BSc, Sanil Bhatia, PhD, Marc Remke, MD, Melf Sönnichsen, M.Sc., Niklas Dienstbier, M.Sc., Ute Fischer, PhD, Julia Hauer, MD, Arndt Borkhardt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3883.
https://doi.org/10.1182/blood-2019-128136
Published: 2019
Journal Articles

Investigation of New Therapeutic Compounds for Juvenile Myelomonocytic Leukemia Using Induced Pluripotent Stem Cells with Stably Activated Ras Pathway

Lisa Maria Kuhn, Cyrill Schipp, PhD, Daniel Hein, PhD, Bianca Killing, Nan Qin, PhD, Vera H Jepsen, M.Sc., Heinz Ahlert, MSc, BSc, Jasmin Bartl, PhD, Viktoria Marquardt, M.Sc., David Pauck, Kai Völtzke, M.Sc., Jonathan Lim, PhD, Gabriel Leprivier, PhD, Marc Remke, MD, Sanil Bhatia, PhD, Thorsten Rosenbaum, MD, Arndt Borkhardt, MD, Ute Fischer, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4651.
https://doi.org/10.1182/blood-2019-131406
Published: 2019
Journal Articles

Therapeutic Targeting of HSP90 in AML and ALL

Sanil Bhatia, PhD, Heinz Ahlert, Msc, Benedikt Frieg, PhD, Arndt Borkhardt, MD, Holger Gohlke, PhD, Thomas Kurz, Julia Hauer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4680.
https://doi.org/10.1182/blood-2018-99-120362
Published: 2018
Journal Articles

Development of Novel Proteasome-HDAC6 Hybrid Inhibitors for Resistant ALL Phenotype

Sanil Bhatia, PhD, Nina Ressing, Alexandra Herrlich, Arndt Borkhardt, Prof MD, Finn Hansen, JProf. Dr., Julia Hauer, Prof. Dr.
Journal: Blood
Blood (2017) 130 (Supplement 1): 2070.
https://doi.org/10.1182/blood.V130.Suppl_1.2070.2070
Published: 2017